AAAAAA
Results:
1-15
|
Results: 15
Authors:
Ralevic, V
Kendall, DA
Jerman, JC
Davis, JB
Middlemiss, DN
Smart, D
Citation: V. Ralevic et al., Low pH modulation of recombinant vanilloid receptors and perivascular capsaicin-sensitive sensory neurotransmission, AUTON NEURO, 88(1-2), 2001, pp. 36-44
Authors:
Darker, JG
Porter, RA
Eggleston, DS
Smart, D
Brough, SJ
Sabido-David, C
Jerman, JC
Citation: Jg. Darker et al., Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor, BIOORG MED, 11(5), 2001, pp. 737-740
Authors:
Porter, RA
Chan, WN
Coulton, S
Johns, A
Hadley, MS
Widdowson, K
Jerman, JC
Brough, SJ
Coldwell, M
Smart, D
Jewitt, F
Jeffrey, P
Austin, N
Citation: Ra. Porter et al., 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor, BIOORG MED, 11(14), 2001, pp. 1907-1910
Authors:
Ralevic, V
Kendall, DA
Jerman, JC
Middlemiss, DN
Smart, D
Citation: V. Ralevic et al., Cannabinoid activation of recombinant and endogenous vanilloid receptors, EUR J PHARM, 424(3), 2001, pp. 211-219
Authors:
Smart, D
Jerman, JC
Gunthorpe, MJ
Brough, SJ
Ranson, J
Cairns, W
Hayes, PD
Randall, AD
Davis, JB
Citation: D. Smart et al., Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology, EUR J PHARM, 417(1-2), 2001, pp. 51-58
Authors:
Jerman, JC
Brough, SJ
Gager, T
Wood, M
Coldwell, MC
Smart, D
Middlemiss, DN
Citation: Jc. Jerman et al., Pharmacological characterisation of human 5-HT2 receptor subtypes, EUR J PHARM, 414(1), 2001, pp. 23-30
Authors:
Smart, D
Sabido-David, C
Brough, SJ
Jewitt, F
Johns, A
Porter, RA
Jerman, JC
Citation: D. Smart et al., SB-334867-A: the first selective orexin-1 receptor antagonist, BR J PHARM, 132(6), 2001, pp. 1179-1182
Authors:
Smart, D
Jerman, JC
Citation: D. Smart et Jc. Jerman, Anandamide: an endogenous activator of the vanilloid receptor, TRENDS PHAR, 21(4), 2000, pp. 134-134
Authors:
Brough, SJ
Jerman, JC
Jewitt, F
Smart, D
Citation: Sj. Brough et al., Characterisation of an endogenous bombesin receptor in CHO/DG44 cells, EUR J PHARM, 409(3), 2000, pp. 259-263
Authors:
Jerman, JC
Brough, SJ
Prinjha, R
Harries, MH
Davis, JB
Smart, D
Citation: Jc. Jerman et al., Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology, BR J PHARM, 130(4), 2000, pp. 916-922
Authors:
Smart, D
Jerman, JC
Brough, SJ
Neville, WA
Jewitt, F
Porter, RA
Citation: D. Smart et al., The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors, BR J PHARM, 129(7), 2000, pp. 1289-1291
Authors:
Smart, D
Gunthorpe, MJ
Jerman, JC
Nasir, S
Gray, J
Muir, AI
Chambers, JK
Randall, AD
Davis, JB
Citation: D. Smart et al., The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1), BR J PHARM, 129(2), 2000, pp. 227-230
Authors:
Chan, WN
Evans, JM
Hadley, MS
Herdon, HJ
Jerman, JC
Parsons, AA
Read, SJ
Stean, TO
Thompson, M
Upton, N
Citation: Wn. Chan et al., Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent, BIOORG MED, 9(2), 1999, pp. 285-290
Authors:
Medhurst, AD
Hirst, WD
Jerman, JC
Meakin, J
Roberts, JC
Testa, T
Smart, D
Citation: Ad. Medhurst et al., Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle, BR J PHARM, 128(3), 1999, pp. 627-636
Authors:
Smart, D
Jerman, JC
Brough, SJ
Rushton, SL
Murdock, PR
Jewitt, F
Elshourbagy, NA
Ellis, CE
Middlemiss, DN
Brown, F
Citation: D. Smart et al., Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR, BR J PHARM, 128(1), 1999, pp. 1-3
Risultati:
1-15
|